Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's.

Carl CooperSamantha Wratten Rebecca Hall Arthur A M BookmanBriana NdifeWolfgang HueberPushpendra Goswami

Published in: Rheumatology and therapy (2022)

The findings support use of ESSDAI and ESSPRI as Sjögren's clinical trials endpoints, as well as in clinical practice and other research settings. Qualitative data exploring meaningful change supports existing minimal clinically important improvement (MCII) thresholds.

Keyphrases

clinical trial
clinical practice
end stage renal disease
ejection fraction
primary care
newly diagnosed
systematic review
disease activity
prognostic factors
randomized controlled trial
rheumatoid arthritis
patient reported outcomes
machine learning
artificial intelligence